MMP9 and cancer: These results indicate that the simultaneous knockdown of uPAR and MMP-9 using RNAi vectors is a promising tool for analysis of the function of downstream signaling pathways as well as the potential vectors for medulloblastoma cancer gene therapy in combination with radiation treatment.